PFIZER - RESPIRATORY DELIVERY PLATFORM
Pfizer - Respiratory Delivery Platform comprises rights to develop, manufacture and commercialize dry powder inhaler delivery platform.
PFIZER - RESPIRATORY DELIVERY PLATFORM
Industry:
Pharmaceutical
Founded:
1849-01-01
Address:
New York, New York, United States
Country:
United States
Status:
Active
More informations about "Pfizer - Respiratory Delivery Platform"
Mylan to Acquire Pfizer Respiratory Delivery Platform
Mylan to Acquire Pfizer Respiratory Delivery Platform Fills another important gap in Mylan’s product portfolio Includes global rights to generic Advair ... Association countries. In the rest of …See details»
Mylan to acquire Pfizer respiratory tech for $17.5M
Nov 9, 2011 Longer-term, Mylan will also use Pfizer's dry-powder delivery platform to develop both brand and generic pharmaceutical products. The company says it will employ "select key …See details»
Pfizer (respiratory delivery platform) - PitchBook
Pfizer (respiratory delivery platform) General Information Description. A right to develop a generic drug. The asset comprises worldwide rights to develop, manufacture and commercialize a …See details»
Mylan to Acquire Pfizer Respiratory Delivery Platform - PR Newswire
Nov 9, 2011 In addition, Pfizer will grant Mylan rights to its dry-powder delivery platform to develop and commercialize additional brand and generic pharmaceutical products, including …See details»
Mylan to Acquire Pfizer Respiratory Delivery Platform
Nov 9, 2011 Mylan Inc. today announced that it has entered into an agreement with Pfizer for the exclusive worldwide rights to develop, manufacture and commercialize Pfizer’s generic …See details»
Pfizer - Respiratory Delivery Platform acquired by Mylan
Mylan acquires Pfizer - Respiratory Delivery Platform on 2011-11-09 for an undisclosed amount. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. ... Save . Summary. …See details»
Mylan gets Pfizer’s respiratory delivery platform, acquires global ...
Nov 9, 2011 Pfizer will also allow Mylan to develop and commercialize other DPI products using the delivery platform, possibly including certain compounds currently in Pfizer’s pipeline. In …See details»
Mylan acquires rights to Pfizer's inhaler technology
Nov 9, 2011 PITTSBURGH — Generic drug maker Mylan has bought rights to a drug delivery platform made by Pfizer that will allow it to make generic versions of two GlaxoSmithKline …See details»
Mylan to buy rights to Pfizer respiratory products - Manufacturing …
Mylan, a US manufacturer of generic and specialist pharmaceuticals, has agreed to buy respiratory products from Pfizer, including the rights to a generic version of GlaxoSmithKline's …See details»
Mylan to acquire Pfizer generic respiratory delivery platform ...
Nov 10, 2011 US generic drug major Mylan (Nasdaq: MYL) has entered into an agreement with global pharma behemoth Pfizer (NYSE: PFE) for the exclusive worldwide rights to dev. …See details»
Industry Update: the Latest Developments in Therapeutic Delivery
Feb 2, 2012 Mylan acquiring Pfizer‘s respiratory platform Mylan announced its acquisition of Pfizer‘s (NY, USA) Sandwich, UK-based respiratory delivery technology. The deal includes …See details»
Mylan to Acquire Pfizer Respiratory Delivery Platform
Nov 9, 2011 As part of the agreement, Mylan will pay for remaining development and capital expenditures to bring products to market. Pfizer will be due a payment of $17.5 million at …See details»
Pfizer to Showcase Scientific Advancements in Respiratory and …
Oct 8, 2024 Presentations highlight momentum of Pfizer’s portfolio of infectious disease prevention and treatment options Pfizer Inc. (NYSE: PFE) will present data across its …See details»
The Power of Partnership in our Mission to Better Connect the
In previous roles, James led business unit strategy for Pfizer’s Oncology and Inflammation and Immunology franchises, and has managed major customer-centered transformations across …See details»
Pfizer makes bid for ResApp and its respiratory diagnosis apps
Apr 14, 2022 Pfizer is offering A$0.115 per share in cash for ResApp, a deal which has been accepted by the company's directors and recommended to shareholders ahead of a vote …See details»
Pfizer moves supply chain to cloud - Financial Times
Sep 11, 2012 In little more than 18 months, Pfizer went from what Mr Cafone describes as “zero shipment traceability” to a device independent platform that has already handled more than …See details»
Mylan To Acquire Pfizer Respiratory Delivery Platform
Mylan Inc. (Nasdaq: MYL) today announced that it has entered into an agreement with Pfizer for the exclusive worldwide rights to develop, manufacture and commercialize Pfizer's generic …See details»
Here’s How Pfizer Is Boldly Moving into Digital Health
Apr 14, 2022 Pharmaceutical companies are diving deeper into digital health. Earlier this week, Pfizer said it would acquire Resapp Health Ltd, a company that develops smartphone …See details»
Mylan to acquire Pfizer inhaler platform - Chain Drug Review
Nov 11, 2011 PITTSBURGH — Mylan Inc. has entered into an agreement with Pfizer for the exclusive global rights to develop, manufacture and commercialize Pfizer’s generic equivalent …See details»
Pfizer Launches PfizerForAll™, a Digital Platform that Helps …
Aug 27, 2024 NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts …See details»